Ginpreet Kaur

2.8k total citations
105 papers, 2.0k citations indexed

About

Ginpreet Kaur is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, Ginpreet Kaur has authored 105 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 17 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Pharmacology. Recurrent topics in Ginpreet Kaur's work include Natural Antidiabetic Agents Studies (11 papers), Curcumin's Biomedical Applications (10 papers) and Diet, Metabolism, and Disease (8 papers). Ginpreet Kaur is often cited by papers focused on Natural Antidiabetic Agents Studies (11 papers), Curcumin's Biomedical Applications (10 papers) and Diet, Metabolism, and Disease (8 papers). Ginpreet Kaur collaborates with scholars based in India, Canada and United States. Ginpreet Kaur's co-authors include Hardeep Singh Tuli, Harpal S. Buttar, Diwakar Aggarwal, Katrin Sak, Chhuttan L. Meena, Vaishali Aggarwal, Nidarshana Chaturvedi Parashar, Manoj Kumar, Jagjit Kaur and Mehmet Varol and has published in prestigious journals such as SHILAP Revista de lepidopterología, Chemical Communications and Brain Research.

In The Last Decade

Ginpreet Kaur

95 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ginpreet Kaur India 26 649 286 253 208 197 105 2.0k
Raju Dash Bangladesh 25 926 1.4× 224 0.8× 306 1.2× 190 0.9× 123 0.6× 86 2.1k
Mohammad Afzal Zargar India 25 898 1.4× 379 1.3× 292 1.2× 263 1.3× 206 1.0× 90 2.4k
Jeongmin Lee South Korea 22 948 1.5× 226 0.8× 200 0.8× 241 1.2× 143 0.7× 145 2.0k
Mohammed M. Ahmed Saudi Arabia 27 518 0.8× 243 0.8× 287 1.1× 253 1.2× 402 2.0× 68 2.0k
Ghadeer M. Albadrani Saudi Arabia 25 644 1.0× 215 0.8× 205 0.8× 232 1.1× 120 0.6× 107 1.9k
Najma Rahu Pakistan 7 584 0.9× 319 1.1× 155 0.6× 191 0.9× 187 0.9× 9 1.9k
Johra Khan Saudi Arabia 22 638 1.0× 259 0.9× 171 0.7× 126 0.6× 146 0.7× 60 2.0k
Hanaa H. Ahmed Egypt 28 613 0.9× 430 1.5× 275 1.1× 216 1.0× 186 0.9× 198 2.5k
Amani E. Khalifa Egypt 24 703 1.1× 326 1.1× 290 1.1× 238 1.1× 154 0.8× 70 2.3k
Muhammad Ajmal Shah Pakistan 27 820 1.3× 452 1.6× 348 1.4× 220 1.1× 202 1.0× 109 2.3k

Countries citing papers authored by Ginpreet Kaur

Since Specialization
Citations

This map shows the geographic impact of Ginpreet Kaur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ginpreet Kaur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ginpreet Kaur more than expected).

Fields of papers citing papers by Ginpreet Kaur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ginpreet Kaur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ginpreet Kaur. The network helps show where Ginpreet Kaur may publish in the future.

Co-authorship network of co-authors of Ginpreet Kaur

This figure shows the co-authorship network connecting the top 25 collaborators of Ginpreet Kaur. A scholar is included among the top collaborators of Ginpreet Kaur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ginpreet Kaur. Ginpreet Kaur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Popli, Harvinder, et al.. (2025). Organs-on-Chips: Revolutionizing Biomedical Research. SHILAP Revista de lepidopterología. 5(3). 38–38.
2.
Kaur, Ginpreet, et al.. (2025). Exploring therapeutic targets in Toll-like receptor pathways: Implications for cardiovascular management in polycystic ovary syndrome. European Journal of Pharmacology. 1001. 177749–177749.
3.
Sharma, Anju, et al.. (2024). Advent of artificial intelligence in orthognathic surgery: Advancements and challenges. SHILAP Revista de lepidopterología. 55(2). 231–243.
4.
Gupta, Dhruv, et al.. (2023). Resveratrol and Its Role in the Management of B-Cell Malignancies—A Recent Update. Biomedicines. 11(1). 221–221. 10 indexed citations
5.
Buttar, Harpal S., et al.. (2023). Challenges and Opportunities of Metal Chelation Therapy in Trace Metals Overload-Induced Alzheimer’s Disease. Neurotoxicity Research. 41(3). 270–287. 30 indexed citations
7.
Buttar, Harpal S., et al.. (2023). Artificial intelligence in diagnosis and management of Huntington’s disease. Beni-Suef University Journal of Basic and Applied Sciences. 12(1). 2 indexed citations
8.
Kumar, Rajiv, et al.. (2023). Cholesterol Homeostasis, Mechanisms of Molecular Pathways, and Cardiac Health: A Current Outlook. Current Problems in Cardiology. 49(1). 102081–102081. 9 indexed citations
10.
Kaur, Ginpreet, et al.. (2023). Cannabinoid receptor 2 (CB2) agonists and l-arginine ameliorate diabetic nephropathy in rats by suppressing inflammation and fibrosis through NF-κβ pathway. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(1). 381–393. 6 indexed citations
11.
Kaur, Ginpreet, et al.. (2023). Exploring the versatility of ciclopirox – from anti-fungal to anticancer agent and beyond. European Journal of Clinical and Experimental Medicine. 21(4). 896–908. 1 indexed citations
12.
Buttar, Harpal S., et al.. (2022). Baicalein: Promising Therapeutic Applications With Special Reference to Published Patents. Pharmaceutical Patent Analyst. 11(1). 23–32. 29 indexed citations
13.
Tuli, Hardeep Singh, Vivek Kumar Garg, Ginpreet Kaur, et al.. (2022). Licorice (Glycyrrhiza glabra L.)-Derived Phytochemicals Target Multiple Signaling Pathways to Confer Oncopreventive and Oncotherapeutic Effects. OncoTargets and Therapy. Volume 15. 1419–1448. 17 indexed citations
14.
Gupta, Dhruv, et al.. (2022). Promising effects of emoxypine and its succinate derivative in the management of various diseases-with insights on recent patent applications. SHILAP Revista de lepidopterología. 3. 100121–100121. 15 indexed citations
15.
Tuli, Hardeep Singh, Ajay Kumar, Katrin Sak, et al.. (2022). Gut Microbiota-Assisted Synthesis, Cellular Interactions and Synergistic Perspectives of Equol as a Potent Anticancer Isoflavone. Pharmaceuticals. 15(11). 1418–1418. 11 indexed citations
16.
Tuli, Hardeep Singh, Sonam Mittal, Vaishali Aggarwal, et al.. (2021). Deguelin targets multiple oncogenic signaling pathways to combat human malignancies. Pharmacological Research. 166. 105487–105487. 26 indexed citations
17.
Kaur, Ginpreet, et al.. (2020). Insulinotropic and antidiabetic effects of β‐caryophyllene with l ‐arginine in type 2 diabetic rats. Journal of Food Biochemistry. 44(4). e13156–e13156. 30 indexed citations
18.
Tuli, Hardeep Singh, Sonam Mittal, Diwakar Aggarwal, et al.. (2020). Path of Silibinin from diet to medicine: A dietary polyphenolic flavonoid having potential anti-cancer therapeutic significance. Seminars in Cancer Biology. 73. 196–218. 78 indexed citations
19.
Kaur, Ginpreet, Meenakshi Arora, Raghu Ganugula, & M. N. V. Ravi Kumar. (2019). Double-headed nanosystems for oral drug delivery. Chemical Communications. 55(33). 4761–4764. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026